International Journal of Molecular Sciences, 2021 · DOI: 10.3390/ijms22084141 · Published: April 16, 2021
This study investigates the potential of peripheral nerve-derived stem cells (PNSCs) in treating spinal cord injury (SCI). PNSCs, isolated from adult peripheral nerves, possess characteristics similar to neural crest stem cells, showing the ability to differentiate into various cell types like Schwann cells and neurons. The research highlights that PNSCs can be enhanced by developing them into spheroids, which secrete more neurotrophic factors and express extracellular matrix. These spheroids have shown promising results in animal SCI models, inducing functional recovery and neuronal regeneration. The findings suggest that these PNSC spheroids could be a new therapeutic approach for SCI patients. They not only promote functional recovery but also reduce neuropathic pain associated with SCI after remyelination.
PNSC spheroids represent a promising cell-based therapy for spinal cord injury, potentially overcoming limitations of existing treatments.
The ease of obtaining adult peripheral nerves for isolating PNSCs makes this approach more clinically feasible than using fetal tissue-derived neural stem cells.
PNSC spheroids can mitigate neuropathic pain, a common complication in SCI patients, by reducing inflammation and promoting remyelination.